Our study provides a novel paradigm for scaffold protein Sur8 as a positive regulator of tumor malignancy through the Ras-PI3K-Rac-MMP signaling and a potential novel therapeutic target for suppressing tumor metastasis that arises from Ras/PI3K-induced activations of both the Raf and Akt pathways. The gene discussed is AKT1; the disease is neoplasm.